Business Context and Reporting Period
This Form 8-K filing by The Chemours Company (CC) was submitted on November 17, 2023, with the earliest event reported on that date. The report details changes to the Company's Board of Directors, specifically the retirement of a director and the appointment of a new member.
Key Financial Metrics
This filing does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Director Departure: Curtis J. Crawford, Ph.D., notified the Board of his decision to retire effective November 22, 2023. The filing states this retirement is not due to any disagreement regarding the Company's operations, policies, or practices.
- Director Appointment: Alister Cowan, BA, CA, was appointed to the Board effective November 22, 2023.
- Board Composition: The appointment maintains the Board size at nine members, with eight qualifying as independent under NYSE listing standards and Chemours' Corporate Governance Guidelines.
Outlook, Risks, and Management Commentary
New Director Background: Mr. Cowan, age 59, brings significant financial experience. He has served as Executive Advisor at Suncor Energy Inc. since 2023, previously serving as its Executive Vice President and CFO (2014–2020) and CFO (2020–2023). Prior to Suncor, he held CFO roles at Husky Energy Inc. (2008–2014).
Compensation and Agreements: Mr. Cowan will receive compensation as a non-employee director in accordance with practices described in the Company's 2023 Annual Proxy Statement. He will also enter into the Company's standard form of indemnification agreement. No family relationships with other executives or directors exist, and no other transactions requiring disclosure under Item 404(a) of Regulation S-K are present.
Committee Assignments: As of the filing date, Mr. Cowan has not yet been appointed to any Board committees.
Investor Verification Checklist
- Verify the effective date of the Board changes (November 22, 2023) against the press release attached as Exhibit 99.1.
- Review the Company's 2023 Annual Proxy Statement for details on non-employee director compensation applicable to Mr. Cowan.
- Confirm the independence status of the nine-member Board under NYSE listing standards.
- Monitor future filings for Mr. Cowan's specific committee assignments.